Three‐Dimensional Quantitative Structure‐Activity Relationship Study of Antitumor 2‐Formylpyridine Thiosemicarbazones Derivatives as Inhibitors of Ribonucleotide Reductase

Abstract

In order to extend previous SAR and QSAR studies, 3D-QSAR analysis has been performed using CoMFA and CoMSIA approaches applied to a set of 39 a-(N)-heterocyclic carboxaldehydes thiosemicarbazones with their inhibitory activity values (IC 50 ) evaluated against ribonucleotide reductase (RNR) of H.Ep.-2 cells (human epidermoid carcinoma), taken from selected literature. Both rigid and field alignment methods, taking the unsubstituted 2-formylpyridine thiosemicarbazone in its syn conformation as template, have been used to generate multiple predictive CoMFA and CoMSIA models derived from training sets and validated with the corresponding test sets. Acceptable predictive correlation coefficients (Q 2 from 0.991 to 0.998 for CoMSIA models) and very low standard errors (s from 0.040 to 0.179 for CoMFA and s from 0.029 to 0.068 for CoMSIA models) were obtained. The stability of each CoMFA and CoMSIA models was further assessed by performing bootstrapping analysis. For the two sets the generated CoMSIA models showed, in general, better statistics than the corresponding CoMFA models. The analysis of CoMFA and CoMSIA contour maps suggest that a hydrogen bond acceptor near the nitrogen of the pyridine ring can enhance inhibitory activity values. This observation agrees with literature data, which suggests that the nitrogen pyridine lone pairs can complex with the iron ion leading to species that inhibits RNR. The derived CoMFA and CoMSIA models contribute to understand the structural features of this class of TSC as antitumor agents in terms of steric, electrostatic, hydrophobic and hydrogen bond donor and hydrogen bond acceptor fields as well as to the rational design of this key enzyme inhibitors.

QSAR and pharmacophore analysis of thiosemicarbazone derivatives as ribonucleotide reductase inhibitors

“…In the literatures, there are some QSAR studies addressed to RNR with comparable antitumor activity (Raichurkar and Kulkarni, 2003;Ren et al, 2002;Ishiki and do Amaral, 2009). The QSAR analyses were performed between the anticancer activity (cancer cell lines) and the physicochemical properties.…”

Aplicação do conceito do par iônico e seus efeitos sobre a lipofilicidade de brometos de amônio quaternários estruturalmente análogos a procaína, com atividade de bloqueio da transmissão neuromuscular, para estudos de <i>(Q)SAR</i>

“…Esta abordagem, embora seja bastante eficaz neste sentido, apresenta limitação em relação à abordagem do aspecto tridimensional das relações ligante-receptor (Kubinyi, 1993;Rusyn et al, 2012;Cherkasov, 2014 (Kubinyi, 1993;Pires et al, 2001;Ishiki & Amaral, 2009;Doweyko, 2004;Malvezzi et al, 2009;Gertzen & Gohlke, 2012;Sliwoski et al, 2016).…”